NUWE · Nuwellis, Inc. · Metrics
$3.50
-0.31 (-8.14%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Nov 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions, including continued operating losses, negative cash flows from operations, an accumulated deficit of $327.7 million, and the need for additional capital to fund ongoing operations and growth initiatives (including the integration of Rendiatech Ltd., an Israeli company (“Rendiatech”) following the Company’s acquisition), raise substantial doubt about the Company’s ability to continue as a going concern for at least twelve months from the date these financial statements are issued. While management’s plans, including recent financing activities, cost discipline initiatives, and contingency measures, are intended to address these conditions, such plans do not alleviate the substantial doubt.”View the 10-Q filed Nov 12, 2026
Market Cap
$2.06M
Shares
540,912
Volume · Nov 20
4835
Avg daily vol (18 sessions)
2.34M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
NUWE metrics
61 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$3.81
Market cap
$2.06M
Price action
23 metricsPrice change (1W)
-24.3%
Price change (30D)
-29.6%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$146.65
52-week low
$0.32
Change from 52-week high
-97.4%
Change from 52-week low
+1,090.6%
Annualized volatility
—
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
35.5
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
540,912
Valuation
12 metricsP / E (TTM)
0.0
Trailing earnings · reciprocal yield 504,205.5%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 437.1%
P / book
0.2
reciprocal yield 477.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-667.7%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
-1.5×
EV / revenue historical average (5Y)
-1.5×
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-11-12
Profitability
9 metricsGross margin
70.8%
Operating margin
-135.8%
Trailing 12 months
Net margin
-152.8%
Gross profit (TTM)
$6.37M
Operating profit (TTM)
−$12.23M
Net income (TTM)
−$13.76M
Trailing 12 months
Diluted EPS (TTM)
$19,210.23
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-0.2%
Year over year
Net income growth YoY
-520.7%
Revenue (TTM)
$9.01M
Trailing 12 months
EPS growth YoY
-103.3%
Shares change YoY
+12,688.5%
Year over year · more shares
Revenue CAGR (3Y)
-1.1%
Revenue CAGR (5Y)
+2.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-139.8%
Return on assets
-102.3%
Debt / equity
—
Current ratio
4.0
EBITDA (TTM)
−$12.09M
Free cash flow (TTM)
—
Quick ratio
3.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$8.29M
Total assets
$13.45M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$12.30M
Capital expenditures (TTM)
$5,000
R&D (TTM)
$4.14M
SG&A (TTM)
$14.47M
Stock compensation (TTM)
$79,000
R&D / revenue
45.9%
Stock compensation / revenue
0.9%
Ownership (13F)
9 metrics13F filers
11
13F filer change QoQ
+6
Institutional ownership
6.0%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
4.8%
Private-fund adviser ownership
1.9%
Active holders' share change QoQ
+5,795.5%
Holder tenure
1.4
Price vs estimated holder cost
—
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
36.2%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
79 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged
Key facts
CIK
1506492
CUSIP
67113Y884
13F (30d)
15 filings
12 filers
Visit website
Investor relations